Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NanoCarrier and Kirin collaborate on anticancer therapeutics

Dec. 12, 2002

Apomine as a new therapeutic approach to multiple myeloma

Dec. 12, 2002

New caspase activators in Cytovia development pipeline

Dec. 12, 2002

Pipecolinate MDR modulators effective in modulating mitoxantrone efflux from AML cells

Dec. 11, 2002

HDAC inhibitor active against multiple myeloma in vitro and in animal model

Dec. 11, 2002

Antitumor activity of Geron's telomerase inhibitor reported in presentation at ASH meeting

Dec. 11, 2002

New proline-based MMP inhibitors in early development at Aventis

Dec. 11, 2002

New proapoptotic compounds identified at Cell Pathways

Dec. 11, 2002

Inhibitors of CDK2, CDK5 and/or GSK-3 covered by Pfizer patent

Dec. 11, 2002

Patent for p53/taxane combination therapy awarded to Aventis, licensed to Introgen

Dec. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...